148 related articles for article (PubMed ID: 15486453)
1. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
Skropeta D; Schwörer R; Haag T; Schmidt RR
Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
[TBL] [Abstract][Full Text] [Related]
2. Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings.
Mathew B; Schmidt RR
Carbohydr Res; 2007 Feb; 342(3-4):558-66. PubMed ID: 16989791
[TBL] [Abstract][Full Text] [Related]
3. New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay.
Schaub C; Müller B; Schmidt RR
Glycoconj J; 1998 Apr; 15(4):345-54. PubMed ID: 9613821
[TBL] [Abstract][Full Text] [Related]
4. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
5. Conformational and electrostatic analysis of S
Crous W; Naidoo KJ
Bioorg Med Chem; 2016 Oct; 24(20):4998-5005. PubMed ID: 27614914
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
Izumi M; Wada K; Yuasa H; Hashimoto H
J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
[TBL] [Abstract][Full Text] [Related]
7. Computational characterisation of the interactions between human ST6Gal I and transition-state analogue inhibitors: insights for inhibitor design.
Montgomery A; Szabo R; Skropeta D; Yu H
J Mol Recognit; 2016 May; 29(5):210-22. PubMed ID: 26669681
[TBL] [Abstract][Full Text] [Related]
8. Studies on the inhibition of sialyl- and galactosyltransferases.
Kleineidam RG; Schmelter T; Schwarz RT; Schauer R
Glycoconj J; 1997 Jan; 14(1):57-66. PubMed ID: 9076514
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric synthesis and reactivity of potent sialyltransferase inhibitors based on transition-state analogues: supplementary data.
Skropeta D; Schwörer R; Haag T; Schmidt RR
Glycoconj J; 2004; 21(5):221-5. PubMed ID: 15486454
[No Abstract] [Full Text] [Related]
10. Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.
Whalen LJ; McEvoy KA; Halcomb RL
Bioorg Med Chem Lett; 2003 Jan; 13(2):301-4. PubMed ID: 12482445
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective synthesis of phosphoramidate alpha(2-6)sialyltransferase transition-state analogue inhibitors.
Skropeta D; Schwörer R; Schmidt RR
Bioorg Med Chem Lett; 2003 Oct; 13(19):3351-4. PubMed ID: 12951124
[TBL] [Abstract][Full Text] [Related]
12. Characterization of inhibitory activities and binding mode of synthetic 6'-modified methyl N-acetyl-beta-lactosaminide toward rat liver CMP-D-Neu5Ac: D-galactoside-(2-->6)-alpha-D-sialyltransferase.
Kajihara Y; Kodama H; Wakabayashi T; Sato K; Hashimoto H
Carbohydr Res; 1993 Sep; 247():179-93. PubMed ID: 8221719
[TBL] [Abstract][Full Text] [Related]
13. Transition State-Based Sialyltransferase Inhibitors: Mimicking Oxocarbenium Ion by Simple Amide.
Guo J; Li W; Xue W; Ye XS
J Med Chem; 2017 Mar; 60(5):2135-2141. PubMed ID: 28165727
[TBL] [Abstract][Full Text] [Related]
14. Sialyltransferase inhibitors: consideration of molecular shape and charge/hydrophobic interactions.
Kumar R; Nasi R; Bhasin M; Huan Khieu N; Hsieh M; Gilbert M; Jarrell H; Zou W; Jennings HJ
Carbohydr Res; 2013 Aug; 378():45-55. PubMed ID: 23374752
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of flavonoids as sialyltransferase inhibitors.
Hidari KI; Oyama K; Ito G; Nakayama M; Inai M; Goto S; Kanai Y; Watanabe K; Yoshida K; Furuta T; Kan T; Suzuki T
Biochem Biophys Res Commun; 2009 May; 382(3):609-13. PubMed ID: 19303395
[TBL] [Abstract][Full Text] [Related]
16. Different reactivity of two brain sialyltransferases towards sulfhydryl reagents. Evidence for a thiol group involved in the nucleotide-sugar binding site of the NeuAc alpha 2-3Gal beta 1-3GalNAc alpha(2-6)sialyltransferase.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Glycoconj J; 1989; 6(1):115-27. PubMed ID: 2485232
[TBL] [Abstract][Full Text] [Related]
17. Efficient sialyltransferase inhibitors based on glycosides of N-acetylglucosamine.
Schwörer R; Schmidt RR
J Am Chem Soc; 2002 Feb; 124(8):1632-7. PubMed ID: 11853437
[TBL] [Abstract][Full Text] [Related]
18. Exploring the substrate specificities of alpha-2,6- and alpha-2,3-sialyltransferases using synthetic acceptor analogues.
Van Dorst JA; Tikkanen JM; Krezdorn CH; Streiff MB; Berger EG; Van Kuik JA; Kamerling JP; Vliegenthart JF
Eur J Biochem; 1996 Dec; 242(3):674-81. PubMed ID: 9022696
[TBL] [Abstract][Full Text] [Related]
19. Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors.
Chang KH; Lee L; Chen J; Li WS
Chem Commun (Camb); 2006 Feb; (6):629-31. PubMed ID: 16446832
[TBL] [Abstract][Full Text] [Related]
20. Determination of the specificities of rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase using synthetic modified acceptors.
Wlasichuk KB; Kashem MA; Nikrad PV; Bird P; Jiang C; Venot AP
J Biol Chem; 1993 Jul; 268(19):13971-7. PubMed ID: 8314763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
